DR. RICHARD JAY WURTMAN, MD
Osteopathic Medicine at Vassar St, Cambridge, MA
License number
Massachusetts 58203
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
2
43 Vassar St, Cambridge, MA 02139
9142 Mass General Physician Organization, Boston, MA 02129
9142 Mass General Physician Organization, Boston, MA 02129
Phone
(617) 253-6731
(617) 253-6882 (Fax)
(617) 724-0287
(617) 726-2894 (Fax)
(617) 253-6882 (Fax)
(617) 724-0287
(617) 726-2894 (Fax)
Professional information
Dr. Richard J Wurtman, Cambridge MA - MD (Doctor of Medicine)
Specialties:
Other, Internal Medicine
Address:
43 Vassar St, Cambridge 02139
(617) 253-6731 (Phone), (617) 253-6882 (Fax)
(617) 253-6731 (Phone), (617) 253-6882 (Fax)
Languages:
English
Education:
Medical School
Harvard Medical School
Graduated: 1960
Harvard Medical School
Graduated: 1960
Richard Jay Wurtman, Cambridge MA
Specialties:
Internal Medicine
Work:
M.I.T
43 Vassar St, Cambridge, MA 02139
43 Vassar St, Cambridge, MA 02139
Education:
Harvard University(1960)
Process And Composition For Treating Disorders By Administering Piracetam And Choline
US Patent:
4355027, Oct 19, 1982
Filed:
Jul 20, 1981
Appl. No.:
6/284768
Inventors:
John H. Growdon - Brookline MA
Richard J. Wurtman - Boston MA
Richard J. Wurtman - Boston MA
Assignee:
Massachusetts Institute of Technology - Cambridge MA
International Classification:
A61K 3140, A61K 31685
US Classification:
424199
Abstract:
Choline or a natural or synthetic compound that dissociates to form choline is administered to a patient concomitantly with piracetam [(oxo-2-pyrrolidinyl-) 2 acetamine] in order to potentiate the effect of the drug by increasing acetylcholine levels in the brain or other tissues, and/or to suppress, or block the development of, unwanted side effects of the drug, by increasing acetylcholine levels in the brain or other tissues.
Process For Utilizing Choline To Sustain Muscular Performance
US Patent:
4626527, Dec 2, 1986
Filed:
Sep 28, 1985
Appl. No.:
6/780053
Inventors:
Richard J. Wurtman - Boston MA
Lydia Conlay - Nahant MA
Krzysztof Blusztajn - Cambridge MA
Lydia Conlay - Nahant MA
Krzysztof Blusztajn - Cambridge MA
Assignee:
Massachusetts Institute of Technology - Cambridge MA
International Classification:
A61K 31685
US Classification:
514 78
Abstract:
Choline or a natural or synthetic compound that dissociates to form choline is administered to a patient who has or is about to participate in major exercise in order to decrease fatigue by increasing acetylcholine levels in the brain or other tissues. The term "fatigue" as used herein means the subjective feeling of tiredness as well as the fatigue of muscles and the actual decrease of performance.
Reducing Post-Prandial Fluctuations In Plasma Concentrations Of Large Neutral Amino Acids (Lnaa)
US Patent:
5206218, Apr 27, 1993
Filed:
Apr 3, 1989
Appl. No.:
7/332871
Inventors:
Richard J. Wurtman - Boston MA
Judith J. Wurtman - Boston MA
Judith J. Wurtman - Boston MA
Assignee:
Interneuron Pharmaceuticals, Inc. - Lexington MA
International Classification:
C07D 3702, A23J 304, A23J 308
US Classification:
514 2
Abstract:
Methods of reducing post-prandial fluctuations in plasma levels of large, neutral amino acids (LNAA), as well as compositions useful in that method. The foods and compositions comprise a carbohydrate to protein ratio of from about 3:1 to about 6:1 and, in a specific embodiment, a ratio of 4:1, which results in minimizing the variability in responses individuals exhibit to drugs which are LNAA.
Uridine Effects On Dopamine Release
US Patent:
2006002, Feb 2, 2006
Filed:
May 11, 2005
Appl. No.:
11/126410
Inventors:
Richard Wurtman - Boston MA, US
International Classification:
A61K 31/7072, A61K 31/685
US Classification:
514051000, 514078000
Abstract:
The present invention provides methods for increasing secretion of dopamine and other neurotransmitters and treating or reducing the incidence of diseases involving decreased secretion of dopamine and other neurotransmitters, e.g. Parkinson's disease, comprising administering to the subject a uridine or a source thereof, and compositions for treating or reducing an incidence of Parkinson's disease, comprising a uridine, a uridine monophosphate, or a source thereof.
Uridine Administration Stimulates Membrane Production
US Patent:
8314064, Nov 20, 2012
Filed:
Oct 26, 2004
Appl. No.:
10/972777
Inventors:
Carol Watkins - Cambridge MA, US
Richard J. Wurtman - Boston MA, US
Richard J. Wurtman - Boston MA, US
Assignee:
Massachusetts Institute of Technology - Cambridge MA
International Classification:
A61K 31/70, A61K 38/18, C07K 14/48
US Classification:
514 84, 514 50, 514 51
Abstract:
The present invention provides methods of stimulating or enhancing production of a cellular membrane, improving a cognitive function or a neurological function, treating or ameliorating a decline in a cognitive function or a neurological function, increasing cytidine levels, or treating a neurological disorder in a subject, comprising administering a uridine, a uridine precursor, or a derivative or metabolite thereof to the subject. The invention also provides methods of improving neural function, comprising contacting the neuron with a uridine, a uridine precursor, or a derivative or metabolite thereof.
Composition And Method For Increasing Levels Or Release Of Brain Serotonin
US Patent:
4687763, Aug 18, 1987
Filed:
Feb 25, 1985
Appl. No.:
6/705174
Inventors:
Richard J. Wurtman - Boston MA
Assignee:
Massachusetts Institute of Technology - Cambridge MA
International Classification:
A61K 3170
US Classification:
514 53
Abstract:
A composition comprising tryptophan and melatonin with or without an insulin-releasing carbohydrate or melatonin and an insulin-releasing carbohydrate is administered to an animal in order to increase the levels or release of brain serotonin.
Process And Composition For Treating Disorders By Administering Isoxsurpine And Choline
US Patent:
4351831, Sep 28, 1982
Filed:
Jan 30, 1981
Appl. No.:
6/229704
Inventors:
John H. Growdon - Brookline MA
Richard J. Wurtman - Boston MA
Richard J. Wurtman - Boston MA
Assignee:
Massachusetts Institute of Technology - Cambridge MA
International Classification:
A61K 31685
US Classification:
424199
Abstract:
Choline or a natural or synthetic compound that dissociates to form choline is administered to a patient concomitantly with a drug in order to potentiate the effect of the drug by increasing acetylcholine levels in the brain or other tissues, and/or to suppress, or block the development of, unwanted side effects of the drug, by increasing acetylcholine levels in the brain or other tissues.
Method For Treating Depression With D-Fenfluramine
US Patent:
4649161, Mar 10, 1987
Filed:
Jun 16, 1986
Appl. No.:
6/874609
Inventors:
Richard J. Wurtman - Boston MA
Judith J. Wurtman - Boston MA
Dermot O'Rourke - Charlestown MA
Judith J. Wurtman - Boston MA
Dermot O'Rourke - Charlestown MA
Assignee:
Massachusetts Institute of Technology - Cambridge MA
International Classification:
A61K 31135
US Classification:
514654
Abstract:
D-fenfluramine is administered to a human patient having seasonal depression or other forms of bipolar depression in order to alleviate or cure the depression.